Abstract
Most of the work on transmitter replacement therapy by means of precursor loading has been directed toward manipulation of neurotransmitters synthesized from aromatic amino acids (47). However, beginning in the mid 1970’s, clinical investigators became interested in the use of choline (Ch) to treat disorders in which too little acetylcholine (ACh) was formed in the brain, or in which the formation of an excess of the neurotransmitter was believed to be desirable. This interest in Ch as a therapeutic agent was triggered by basic research showing that the administration of Ch to laboratory animals could cause an increase in the level of ACh in the brain, a phenomenon first described in 1972 by Kuntscherova (32). Although the beneficial effects of Ch in some disorders such as tardive dyskinesia (see 2) may reside in other properties of the molecule (e.g. a direct postsynaptic muscarinic action of Ch has been demonstrated (9,20,31)), there is evidence that part of the effect of Ch is elicited through stimulation of ACh synthesis and release. This evidence is reviewed in the first part of this report.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aquilonius, S.M. and Eckernas, S.A. (1975): New Eng. J. Med. 293:1105–1106.
Barbeau, A., Growdon5 J.H. and Wurtman, R.J. (eds) (1979): Nutrition and the Brain, Vol. 5, Raven Press, New York.
Bernheim, F. and Bernheim, M.C.C. (1938): Amer. J. Physiol. 121:55–60.
Birks, R. and MacIntosh, F.C. (1961): Canad. J. Biochem. Physiol. 39:787–827.
Bowers, M.B. Jr. (1967): Life Sci. 6: 1927–1933.
Brown, L. and Feldberg, W. (1936): J. Physiol. 88:265–283.
Carlsson, A. and Lindqvist, M. (1973): J. Neural. Trans. 34: 79–91.
Cohen, E.L. and Wurtman, R.J. (1975): Life Sci. 16:1095–1102.
Consolo, S., Ladinsky, H. and Gomeni, R. (1979): Pharmacol. Res. Comm. 11:903–918.
Davis, K.L., Hollister, L.E., Barchas, J.D. and Berger, P. A.(1976): Life Sci. 19: 1507–1516.
DeLaHuerga, J. and Popper, H. (1951): J. Clin. Invest. 30: 463–470.
Eckernas, S.A. (1977): Acta Physiol. Scand. 449 (Suppl.).
Flentge, F. and Vanderberg5 C.J. (1979): J. Neurochem. 32: 1331–1333.
Friesen, A.J.D., Ling, G.M. and Nagai, M. (1967): Nature 214: 722–724.
Growdon, J.H., Hirsch, M.J., Wurtman, R.J. and Weiner, W.(1977):New Eng. J. Med. 297:524–527.
Haubrich, D.R. (1973): J. Neurochem. 21:315–328.
Haubrich, D.R. and Chippendale, T.J. (1977): Life Sci. 20: 1465–1478.
Haubrich, D.R. and Goldberg, M.E. (1975): Neuropharmacology 14:211–214.
Haubrich, D.R. and Pflueger, A.B. (1979): Life Sci. 24: 1083–1090.
Haubrich, D.R., Risley, E.A. and Williams, M. (1979): Biochem. Pharmacol. 28:3673–3674.
Haubrich, D.R. and Wang, P.F.L. (1976): Biochem. Pharmacol. 25: 669–672.
Haubrich, D.R., Wang, P.F.L., Clody, D.E. and Wedeking, P.W. (1975): 17:975–980.
Haubrich, D.R., Wang, P.F.L., Herman, R.L. and Clody, D.E. (1975): Life Sci. 17:739–748.
Haubrich, D.R., Wang, P.F.L. and Wedeking, P. (1974): Fed. Proc. 33:477.
Haubrich, D.R., Wang, P.F.W, and Wedeking, P.W. (1975): J. Pharmacol. Exp. Ther. 193:246–255.
Haubrich, D.R., Wedeking, P.W. and Wang, P.F.L. (1974): Life Sci. 14:921–927.
Hebb, C. (1972): Physiol. Rev. 52:918–957.
Hirsch, M.J., Growdon, J.H. and Wurtman, R.J. (1977): Brain Res. 125:383–385.
Hollister, L.E., Jenden, D.J., Amaral, J.R.D., Barchas, J.D., Davis, K.L. and Berger, P.A. (1978): Life Sci. 22:17–22.
Krell, R.D. and Goldberg, A.M. (1975): Biochem. Pharmacol. 24:. 391–396.
Krnjevic, K. and Reinhardt, W. (1979): Science 206: 1321–1323.
Kuntscherova, J. (1972): Physiol. Bohem. 21: 655–660.
London, E.D. and Coyle, J.T. (1978): Biochem. Pharmacol. 27: 2962–2965.
Mann, P.J.G. and Quastel, J.H. (1937): Biochem. J. 31: 869–878.
Neill, A.R., Grime, D.W. and Dawson, R.M.C. (1978): 170: 529–535
Pedata, F., Wieraszko, A. and Pepeu, G. (1977): Pharmacol. Res. Comm. 9: 755–761.
Racagni, G., Trabucchi, M. and Cheney, D.L. (1975): N.-S. Arch. Pharmacol. 290: 99–105.
Re., O. (1974): Curr. Ther. Res. 16: 1238–1242.
Sethy, V.H., Kuhar, M.J., Roth, R.H., Van Woert, M.H. and Aghajanian, G.K. (1973): 55:481–484.
Smith, J.C., Cavallito, C.J. and Foldes, F.F. (1967): Biochem. Pharmacol. 16:2438–2441.
Ulus, I.H. and Wurtman, R.J. (1976): Science 194:1060–1061.
Wecker, L. and Dettbarn, W.D. (1979): J. Neurochem. 32.:961–967.
Wecker, L., Dettbarn, W.D. and Schmidt, D. (1978): Science 199:86–87.
Wecker, L. and Schmidt, D.E. (1978): Soc. Neurosci. Abst. 4:436
White, H.L. and Wu, J.C. (1973): J. Neurochem. 20:297–307.
Wittenberg, J. and Kornberg, A. (1953): J. -Biol. Chem. 202: 431–444.
Wurtman, R.J. (1979): IN Nutrition and the Brain, Vol. 5 (eds) A. Barbeau, J.H. Growdon and R.J. Wurtman, Raven Press, New York, pp. 1–12
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Haubrich, D.R., Gerber, N.H., Pflueger, A.B., Pouch, W.J. (1981). Choline Availability and the Synthesis of Acetylcholine. In: Pepeu, G., Ladinsky, H. (eds) Cholinergic Mechanisms. Advances in Behavioral Biology, vol 25. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8643-8_43
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8643-8_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8645-2
Online ISBN: 978-1-4684-8643-8
eBook Packages: Springer Book Archive